See What HealthDay Can Do For You
Contact Us

June 2008 Briefing - Nephrology

Here are what the editors at HealthDay consider to be the most important developments in Nephrology for June 2008. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Gastric Bypass May Raise Risk of Kidney Stones

MONDAY, June 30 (HealthDay News) -- Morbidly obese patients who undergo Roux-en-Y gastric bypass are at risk of developing kidney stones as early as three months after surgery, researchers report in the June issue of the Journal of the American College of Surgeons.

Abstract
Full Text (subscription or payment may be required)

Higher Albuminuria Levels Associated with Hypertension

MONDAY, June 30 (HealthDay News) -- Having a higher albumin/creatinine ratio -- even if it's in the range considered "normal" -- is associated with an increased risk of incident hypertension in women without diabetes, according to a report published online June 25 in the Journal of the American Society of Nephrology.

Abstract
Full Text (subscription or payment may be required)

One in Eight Taiwanese Has Chronic Kidney Disease

FRIDAY, June 27 (HealthDay News) -- About 12 percent of the Taiwanese population has chronic kidney disease, which nearly doubles their risk of death, though most are unaware that they have the disorder, researchers report in the June 28 issue of The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial

Weight Gain Increases Risk of Chronic Kidney Disease

TUESDAY, June 24 (HealthDay News) -- Weight gain over time increases the risk of developing chronic kidney disease, even in men whose weight is in the normal range, according to the results of a study released online May 21 in advance of publication in the Journal of the American Society of Nephrology.

Abstract
Full Text (subscription or payment may be required)

Article Examines Use of 'Key Opinion Leaders' in Drug Sales

FRIDAY, June 20 (HealthDay News) -- Influential doctors known as "key opinion leaders" are paid generous fees to influence their peers to prescribe a company's drugs and may in fact be considered salespeople by the industry, according to an article in the June 21 issue of BMJ.

Full Text - Moynihan
Editorial - Buckwell
Editorial - Fava

Statins Benefit Kidney Disease Patients with Dyslipidemia

FRIDAY, June 20 (HealthDay News) -- Patients with mild-to-moderate chronic kidney disease (CKD) are prone to abnormal lipid metabolism, which can be treated effectively with statins, but evidence of statins' effectiveness in hemodialysis patients is inconclusive, researchers report in the June 24 issue of the Journal of the American College of Cardiology.

Abstract
Full Text (subscription or payment may be required)

Model Compares Post-Kidney Transplant Drug Regimens

THURSDAY, June 19 (HealthDay News) -- A calcineurin inhibitor (CNI) withdrawal regimen for de novo kidney transplant patients was associated with better long-term patient and graft survival, compared with common CNI-containing immunosuppressive therapies, according to research published online June 18 in the Journal of the American Society of Nephrology.

Abstract
Full Text (subscription or payment may be required)

Subclinical Hypothyroidism Linked to Kidney Disease

FRIDAY, June 13 (HealthDay News) -- People with poor kidney function appear to have a greater frequency of subclinical primary hypothyroidism than those with normal kidney function, with the prevalence rising as kidney function declines, according to a report published online June 11 in the Clinical Journal of the American Society of Nephrology.

Abstract
Full Text (subscription or payment may be required)

'Transplant Tourism' May Be Inappropriate Term

FRIDAY, June 13 (HealthDay News) -- When patients cross borders to receive organ transplants, there may be serious ethical, clinical, social and economic problems, which the term "transplant tourism" does not suggest, according to an article in the June 14 issue of BMJ.

Abstract - Turner
Full Text (subscription or payment may be required)
Abstract - Noorani
Full Text (subscription or payment may be required)

Experts Debate Whether Organ Donors Should Be Paid

FRIDAY, June 13 (HealthDay News) -- The high success rate of kidney transplants has created demand for organ donations that far exceeds supply and raises ethical dilemmas about paying donors, according to a series of articles in the June 14 issue of BMJ.

Full Text - Matas
Full Text - Chapman
Editorial

Myeloma Drug Relieves Lupus Pathology in Mice

WEDNESDAY, June 11 (HealthDay News) -- Treating mice with lupus with bortezomib, a drug approved to treat multiple myeloma, eliminates autoreactive plasma cells, reduces glomerulonephritis and improves survival, according to study findings published online June 8 in Nature Medicine.

Abstract
Full Text (subscription or payment may be required)

Mild Hypothermia Can Reduce Post-Ischemic Injury

FRIDAY, June 6 (HealthDay News) -- Use of mild hypothermia following an ischemic injury appears to reduce permanent damage to tissue function if treatment is administered within hours of the event and, following treatment, the body is re-warmed slowly, researchers report in the June 7 issue of The Lancet.

Abstract
Full Text (subscription or payment may be required)

Prevalence of Conn's Syndrome Lower Than Thought

FRIDAY, June 6 (HealthDay News) -- The prevalence of hyperaldosteronism, also known as Conn's syndrome, in people with hypertension is much lower than previously thought, according to a report in the June 7 issue of The Lancet.

Abstract
Full Text (subscription or payment may be required)

Drug Relieves Anemia in Chronic Kidney Disease

FRIDAY, June 6 (HealthDay News) -- Intravenous ferumoxytol, an iron oxide nanoparticle, is more effective than oral iron in alleviating anemia in patients with chronic kidney disease, according to the results of a study published online June 4 in the Journal of the American Society of Nephrology.

Abstract
Full Text (subscription or payment may be required)

Aliskiren May Protect Against Diabetic Nephropathy

WEDNESDAY, June 4 (HealthDay News) -- Type 2 diabetics struggling with nephropathy and hypertension had significantly lower albumin levels following treatment with losartan and aliskiren, a newly FDA-approved drug, according to a report in the June 5 issue of the New England Journal of Medicine.

Abstract
Full Text (subscription or payment may be required)
Editorial

Liver, Kidney Disease Linked in Type 2 Diabetes

WEDNESDAY, June 4 (HealthDay News) -- In people with type 2 diabetes, non-alcoholic fatty liver disease is associated with a moderately increased risk of chronic kidney disease, according to research released online April 2 in advance of publication in an upcoming issue of the Journal of the American Society of Nephrology.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing
undefined
undefinedundefined